These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 9054717)

  • 1. Assessing erythropoiesis and the effect of erythropoietin therapy in renal disease by reticulocyte counting.
    Pradella M; Cavill I; d'Onofrio G
    Clin Lab Haematol; 1996 Dec; 18 Suppl 1():35-7. PubMed ID: 9054717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo effects of recombinant human erythropoietin on bone marrow hematopoiesis in patients with chronic renal failure.
    Biljanović-Paunović L; Djukanović L; Lezaić V; Stojanović N; Marisavljević D; Pavlović-Kentera V
    Eur J Med Res; 1998 Dec; 3(12):564-70. PubMed ID: 9889177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Reticulocyte response after immediate withdrawal of recombinant human erythropoietin in chronic hemodialysis patients].
    Caramelo C; Soto C; Neira F; López MD; Jiménez S; Albalate M; de Oña R; Llamas P; Deudero JJ
    Nefrologia; 2004; 24(4):351-6. PubMed ID: 15455495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of indicators of erythropoiesis stimulated by recombinant human erythropoietin in renal anemia.
    Schmidt G; Stamminger G; Daniel A; Gross J; Syllm-Rapoport I; Lun A; Zoellner K
    Biomed Biochim Acta; 1990; 49(2-3):S275-9. PubMed ID: 2386517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human erythropoietin for anaemia associated with chronic renal failure in predialysis patients.
    Schaefer RM; Schaefer L; Heidland A
    Przegl Lek; 1992; 49(1-2):41-2. PubMed ID: 1455005
    [No Abstract]   [Full Text] [Related]  

  • 6. Reticulocyte population data in different erythropoietic states.
    Zini G; Di Mario A; Garzia M; Bianchi M; d'Onofrio G
    J Clin Pathol; 2011 Feb; 64(2):159-63. PubMed ID: 21262778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of effective and total erythropoiesis in myelodysplasia using serum transferrin receptor and erythropoietin concentrations, with automated reticulocyte parameters.
    Bowen DT; Culligan D; Beguin Y; Kendall R; Willis N
    Leukemia; 1994 Jan; 8(1):151-5. PubMed ID: 8289479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma erythropoietin levels in patients undergoing long-term hemodialysis.
    Raich PC; Korst DR
    Arch Pathol Lab Med; 1978 Feb; 102(2):73-5. PubMed ID: 579968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of interleukin-10 in serum and erythropoietin sensitivity in ESRD patients on hemodialysis.
    Attia FM; Tawfik GA; Kalil KA; Mossalam MF
    Int J Lab Hematol; 2010 Oct; 32(5):524-9. PubMed ID: 20148986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reticulocyte response to endogenous erythropoietin after renal transplantation.
    Serre AF; Souweine B; Evreux O; Bonhomme J; Baguet JC; Deteix PM
    Clin Transplant; 1994 Aug; 8(4):353-7. PubMed ID: 7949538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric reticulocyte maturity index: a useful laboratory parameter of erythropoietic activity in anemia.
    Davis BH; Ornvold K; Bigelow NC
    Cytometry; 1995 Mar; 22(1):35-9. PubMed ID: 7587731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin converting enzyme inhibitors impair recombinant human erythropoietin induced erythropoiesis in patients with chronic renal failure.
    Qureshi IZ; Abid K; Ambreen F; Qureshi AL
    Saudi Med J; 2007 Feb; 28(2):193-6. PubMed ID: 17268695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interaction between heart failure and other heart diseases, renal failure, and anemia.
    Silverberg DS; Wexler D; Iaina A; Schwartz D
    Semin Nephrol; 2006 Jul; 26(4):296-306. PubMed ID: 16949468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of response to treatment with recombinant human erythropoietin in anaemia associated with cancer.
    Beguin Y
    Med Oncol; 1998 Aug; 15 Suppl 1():S38-46. PubMed ID: 9785336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure.
    Opasich C; Cazzola M; Scelsi L; De Feo S; Bosimini E; Lagioia R; Febo O; Ferrari R; Fucili A; Moratti R; Tramarin R; Tavazzi L
    Eur Heart J; 2005 Nov; 26(21):2232-7. PubMed ID: 15987710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepcidin-25 is a marker of the response rather than resistance to exogenous erythropoietin in chronic kidney disease/chronic heart failure patients.
    van der Putten K; Jie KE; van den Broek D; Kraaijenhagen RJ; Laarakkers C; Swinkels DW; Braam B; Gaillard CA
    Eur J Heart Fail; 2010 Sep; 12(9):943-50. PubMed ID: 20601671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in erythropoietic agents in renal anemia.
    Macdougall IC
    Semin Nephrol; 2006 Jul; 26(4):313-8. PubMed ID: 16949470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin and renal failure.
    Macdougall IC
    Curr Hematol Rep; 2003 Nov; 2(6):459-64. PubMed ID: 14561389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anaemia, iron studies and erythropoietin in patients of chronic renal failure.
    Singh NP; Aggarwal L; Singh T; Anuradha S; Kohli R
    J Assoc Physicians India; 1999 Mar; 47(3):284-90. PubMed ID: 10999121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure.
    Cowgill LD; James KM; Levy JK; Browne JK; Miller A; Lobingier RT; Egrie JC
    J Am Vet Med Assoc; 1998 Feb; 212(4):521-8. PubMed ID: 9491159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.